home / stock / pbla / pbla news

PBLA News and Press, Panbela Therapeutics Inc Com From 11/29/23

Stock Information
Company Name: Panbela Therapeutics Inc Com
Stock Symbol: PBLA
Market: NASDAQ
Website: panbela.com
Menu
PBLA PBLA Quote PBLA Short PBLA News PBLA Articles PBLA Message Board
Get PBLA Alerts

News, Short Squeeze, Breakout and More Instantly...
PBLA - Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification

MINNEAPOLIS, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA) , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announces that the independent Data Safety Monitoring Board (DSMB) of the Phase 3...
PBLA - Panbela Therapeutics files to sell 4.26M shares of common stock for holders

2023-11-22 17:12:00 ET More on Panbela Therapeutics Seeking Alpha’s Quant Rating on Panbela Therapeutics Historical earnings data for Panbela Therapeutics Financial information for Panbela Therapeutics For further details see: Panbela Therapeutics ...

PBLA - Panbela Therapeutics, Inc. (PBLA) Q3 2023 Earnings Call Transcript

2023-11-10 22:15:08 ET Panbela Therapeutics, Inc. (PBLA) Q3 2023 Earnings Conference Call November 09, 2023, 04:30 PM ET Company Participants James Carbonara - IR Jennifer Simpson - CEO Sue Horvath - CFO Conference Call Participants Jonathan Aschoff -...

PBLA - Panbela Therapeutics GAAP EPS of -$2.69 misses by $0.63

2023-11-09 16:43:27 ET More on Panbela Therapeutics Seeking Alpha’s Quant Rating on Panbela Therapeutics Historical earnings data for Panbela Therapeutics Financial information for Panbela Therapeutics For further details see: Panbela Therapeutics ...
PBLA - Panbela Provides Business Update and Reports Q3 2023 Financial Results

MINNEAPOLIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the...

PBLA - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

PBLA - Expected earnings - Panbela Therapeutics Inc.

Panbela Therapeutics Inc. (PBLA) is expected to report $-2.06 for Q3 2023
PBLA - Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds Priced At-the-Market

MINNEAPOLIS, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced it has entered into agreements with certa...

PBLA - 24/7 Market News Lunch Break 2 Nov 2023

2023-11-02 12:16:20 ET DENVER, Colo., Nov. 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Palantir Technologies Inc (NYSE: PLTR), Panbela Therapeutics Inc (NASDAQ: PBLA), Joby Aviation Inc (NYS...

PBLA - 24/7 Market News Snapshot 2 Nov 2023

2023-11-02 10:00:21 ET DENVER, Colo., Nov. 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Palantir Technologies Inc (NYSE: PLTR), Panbela Therapeutics Inc (NASDAQ: PBLA), Joby Aviation Inc (NYSE: JOBY...
Previous 10 Next 10